-
Something wrong with this record ?
Evaluation of phage therapy in the treatment of Staphylococcus aureus-induced mastitis in mice
H. Geng, W. Zou, M. Zhang, L. Xu, F. Liu, X. Li, L. Wang, Y. Xu,
Language English Country United States
Document type Evaluation Study, Journal Article
Grant support
No. 2018YFD0500600
National Key R&D Program of China
Grant No. 201405003
National Public Science and Technology Research Funds Projects of Ocean
- MeSH
- Bacteriophages physiology MeSH
- Phage Therapy methods veterinary MeSH
- Mastitis, Bovine microbiology therapy MeSH
- Milk microbiology MeSH
- Myoviridae physiology MeSH
- Mice MeSH
- Podoviridae physiology MeSH
- Cattle MeSH
- Staphylococcal Infections microbiology veterinary MeSH
- Staphylococcus aureus physiology virology MeSH
- Animals MeSH
- Check Tag
- Mice MeSH
- Cattle MeSH
- Female MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Evaluation Study MeSH
- Geographicals
- China MeSH
Mastitis in dairy cows is generally considered to be the most expensive disease for dairy farmers worldwide. The overuse of antibiotics is a major problem in the treatment of bovine mastitis, and bacteriophage therapy is expected to provide an alternative treatment. The primary aim of this study was to evaluate the efficacy of a phage cocktail against mastitis in a mouse model. First, a Staphylococcus aureus strain was isolated from milk samples taken from mastitis cows from dairy farms in Xinjiang, China, and it was designated as Sau-XJ-21. Next, two phages (designated as vBSM-A1 and vBSP-A2) with strong lytic activity against Sau-XJ-21 were isolated from mixed sewage samples collected from three cattle farms in Xinjiang. Phages vBSM-A1 and vBSP-A2 were identified as members of the Myoviridae and Podoviridae families, respectively. The two phages exhibited a wide range of hosts, especially phage vBSM-A1. To evaluate the effectiveness of the two phages in the treatment against mastitis, female lactating mice were used 10-14 days after giving births. The mice were divided into six groups; one group was kept as healthy control, while the remaining five groups were inoculated with the isolated S. aureus strain to induce mastitis. Four hours after bacterial inoculation, mice in these groups were injected with 25 μL phosphate buffer saline (negative control), ceftiofur sodium (positive control), or phage, either individually or as a cocktail. The mice were sacrificed 20 h later, and the mammary glands were removed and subjected to further analysis, including the quantitation of colony-forming units (CFU), plaque-forming units (PFU), and gross macroscopic as well as histopathology observation. Mice with induced mastitis exhibited significantly improved mastitic pathology and decreased bacterial counts after they had been given phage treatments, with the phage cocktail being more superior than either phage alone. Furthermore, the cocktail treatment also maintained the highest intramammary phage titer without spreading systemically. The effectiveness of the phage cocktail was comparable to that produced by ceftiofur sodium. According to the data obtained for the mouse model of mastitis, phage therapy could be considered as an innovative alternative to antibiotics for the treatment of bovine mastitis.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20024268
- 003
- CZ-PrNML
- 005
- 20201208102230.0
- 007
- ta
- 008
- 201208s2020 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s12223-019-00729-9 $2 doi
- 035 __
- $a (PubMed)31256341
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Geng, Huijun $u School of Life Science and Biotechnology, Dalian University of Technology, Dalian, 116024, People's Republic of China.
- 245 10
- $a Evaluation of phage therapy in the treatment of Staphylococcus aureus-induced mastitis in mice / $c H. Geng, W. Zou, M. Zhang, L. Xu, F. Liu, X. Li, L. Wang, Y. Xu,
- 520 9_
- $a Mastitis in dairy cows is generally considered to be the most expensive disease for dairy farmers worldwide. The overuse of antibiotics is a major problem in the treatment of bovine mastitis, and bacteriophage therapy is expected to provide an alternative treatment. The primary aim of this study was to evaluate the efficacy of a phage cocktail against mastitis in a mouse model. First, a Staphylococcus aureus strain was isolated from milk samples taken from mastitis cows from dairy farms in Xinjiang, China, and it was designated as Sau-XJ-21. Next, two phages (designated as vBSM-A1 and vBSP-A2) with strong lytic activity against Sau-XJ-21 were isolated from mixed sewage samples collected from three cattle farms in Xinjiang. Phages vBSM-A1 and vBSP-A2 were identified as members of the Myoviridae and Podoviridae families, respectively. The two phages exhibited a wide range of hosts, especially phage vBSM-A1. To evaluate the effectiveness of the two phages in the treatment against mastitis, female lactating mice were used 10-14 days after giving births. The mice were divided into six groups; one group was kept as healthy control, while the remaining five groups were inoculated with the isolated S. aureus strain to induce mastitis. Four hours after bacterial inoculation, mice in these groups were injected with 25 μL phosphate buffer saline (negative control), ceftiofur sodium (positive control), or phage, either individually or as a cocktail. The mice were sacrificed 20 h later, and the mammary glands were removed and subjected to further analysis, including the quantitation of colony-forming units (CFU), plaque-forming units (PFU), and gross macroscopic as well as histopathology observation. Mice with induced mastitis exhibited significantly improved mastitic pathology and decreased bacterial counts after they had been given phage treatments, with the phage cocktail being more superior than either phage alone. Furthermore, the cocktail treatment also maintained the highest intramammary phage titer without spreading systemically. The effectiveness of the phage cocktail was comparable to that produced by ceftiofur sodium. According to the data obtained for the mouse model of mastitis, phage therapy could be considered as an innovative alternative to antibiotics for the treatment of bovine mastitis.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a bakteriofágy $x fyziologie $7 D001435
- 650 _2
- $a skot $7 D002417
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a mastitida skotu $x mikrobiologie $x terapie $7 D008414
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a mléko $x mikrobiologie $7 D008892
- 650 _2
- $a Myoviridae $x fyziologie $7 D017900
- 650 _2
- $a fágová terapie $x metody $x veterinární $7 D000071059
- 650 _2
- $a Podoviridae $x fyziologie $7 D017902
- 650 _2
- $a stafylokokové infekce $x mikrobiologie $x veterinární $7 D013203
- 650 _2
- $a Staphylococcus aureus $x fyziologie $x virologie $7 D013211
- 651 _2
- $a Čína $7 D002681
- 655 _2
- $a hodnotící studie $7 D023362
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Zou, Wei $u School of Life Science and Biotechnology, Liaoning Normal University, Dalian, 116029, People's Republic of China.
- 700 1_
- $a Zhang, Meixia $u School of Life Science and Biotechnology, Dalian University of Technology, Dalian, 116024, People's Republic of China.
- 700 1_
- $a Xu, Le $u School of Life Science and Biotechnology, Dalian University of Technology, Dalian, 116024, People's Republic of China.
- 700 1_
- $a Liu, Fanming $u School of Life Science and Biotechnology, Liaoning Normal University, Dalian, 116029, People's Republic of China.
- 700 1_
- $a Li, Xiaoyu $u School of Life Science and Biotechnology, Dalian University of Technology, Dalian, 116024, People's Republic of China.
- 700 1_
- $a Wang, Lili $u School of Life Science and Biotechnology, Dalian University of Technology, Dalian, 116024, People's Republic of China.
- 700 1_
- $a Xu, Yongping $u School of Life Science and Biotechnology, Dalian University of Technology, Dalian, 116024, People's Republic of China. ghj_abtnl@sina.com. Ministry of Education Center for Food Safety of Animal Origin, Dalian, 116600, People's Republic of China. ghj_abtnl@sina.com.
- 773 0_
- $w MED00011005 $t Folia microbiologica $x 1874-9356 $g Roč. 65, č. 2 (2020), s. 339-351
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31256341 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20201208 $b ABA008
- 991 __
- $a 20201208102226 $b ABA008
- 999 __
- $a ok $b bmc $g 1593223 $s 1114949
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 65 $c 2 $d 339-351 $e 20190630 $i 1874-9356 $m Folia microbiologica $n Folia microbiol. (Prague) $x MED00011005
- GRA __
- $a No. 2018YFD0500600 $p National Key R&D Program of China
- GRA __
- $a Grant No. 201405003 $p National Public Science and Technology Research Funds Projects of Ocean
- LZP __
- $a Pubmed-20201208